Fairvalue-Calculator Fairvalue-Calculator
EN DE

RUA Life Sciences plc (RUA) Fair Value & Analysis

Healthcare · GB · Market cap 10.9M GBX

Pricep0.1775
Fair Valuep0.0700
Upside-60.6%
Quality95/100
Evidence: Medium Range p0.0700 – p0.0700

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

RUA Life Sciences plc (RUA) currently trades at p0.1775, while our model-based Fair Value estimate is p0.0700 — implying the stock looks roughly 60.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also engages in the development and commercialization of bore polymer sealed grafts and soft tissue patches; and development of tri-leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is RUA Life Sciences plc (RUA) undervalued?
As of Jun 26, 2026, our model estimates a fair value of p0.0700 versus a price of p0.1775 — about −61% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RUA?
Our 21-model fair value for RUA Life Sciences plc is p0.0700 (as of Jun 26, 2026), built from audited fundamentals. The current price is p0.1775.
What is the quality score of RUA?
RUA Life Sciences plc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.